BRAF and melanoma: In addition, chronic exposure of cultured melanoma cells to BRAF and/or MEK inhibitors (54, 78) and melanocytic antigen-specific T cells (103) promotes the invasive switch, a phenotype that can be recapitulated in vivo (7, 104, 105).